Estamos no ar no !
Saiba mais
Nordicus Partners
Sobre: Nordicus Partners Corp specializes in developing breakthrough therapeutics for diseases with unmet medical needs. The Company focuses on acquiring and developing drugs from biotech companies in the Nordics, a region known for its scientists, life sciences ecosystem, and drug discoveries and developments. Its current portfolio includes the preclinical biotechnology companies Orocidin A/S, Bio-Convert A/S, and NoviThera ApS. The Company is dedicated to developing breakthrough therapeutics in diseases with unmet medical needs, starting with oral disorders. It operates in the segment focused on developing medicines supporting oral health.
Notícias
Positiva
Neutra
Negativa
Sentimento
3 meses
Positiva
0%
Neutra
0%
Negativa
0%
Não recebemos notícias recentes sobre NORD
Gráficos de preços implementados com Lightweight Charts™